Vera Therapeutics Inc.

10/29/2021 | Press release | Archived content

Atacicept Reduces Serum Gd-IgA1 by Quartiles in IgAN Patients (060dce)

Vera Therapeutics Inc. published this content on October 29, 2021, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 16, 2025 at 09:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io